Imagine getting imperceptibly high, then playing Chinese strategy game 'Go'. This is the experiment the Beckley Foundation will run to test the value of LSD microdosing.
Psychedelics came en vogue in the 1960s and since then have been maligned as inducing psychosis. Today, some evidence suggests that tiny doses of these drugs may be useful for curing psychological disorders such as depression, PTSD, and social anxiety, among others. But more research is needed and there are hurdles to overcome.
Psychedelic mushrooms may be the explanation to how the human neocortex experienced a dramatic evolutionary change from early hominids to homo sapiens.
While progress has been made in understanding the mechanisms behind consciousness, a seemingly limitless neuronal interaction makes discovering a point of origin challenging.
While we usually associate yoga with flexibility-inspired exercise, evidence shows a lack of psychedelic mushroom tea could lie at the foundation of this discipline.
Marijuana might steal the headlines, but psychedelics are making headway in the American consciousness. DMT: The Spirit Molecule producer/director Mitch Schultz discusses this trend.
Psychedelics like psilocybin and LSD are being researched again after a 40-year hiatus, and the results are promising, from both a scientific and spiritual perspective.
In a study of 130,000 American adults, including 19,299 psychedelics users, researchers failed to find evidence that taking psychotropic substances results in serious mental health problems.
Hallucinogenic mushrooms are classified as a Schedule 1 drug in the United States, meaning they are considered to have the highest potential for abuse and lack any medical application.
Scientists and mathematicians hope to unlock the secrets of psilocybin, a compound found in magic mushrooms, in order to better understand how networks in the brain connect in uninhibited states.
"In the information age, you don't teach philosophy as they did after feudalism. You perform it. If Aristotle were alive today he'd have a talk show."
-Timothy Leary
1. Don’t Let Math Get in the Way of Big Ideas “Many of the most successful scientists in the world today are mathematically no more than semiliterate.” E.O. Wilson shares […]
Dr. Oliver Sacks’ 2013 book Hallucinations is a tremendous anthology of case studies of hallucinatory experiences recorded through his decades of work as a clinical neurologist, his analysis of clinical […]
British researchers say that government banning on mind-altering drugs interferes with their experimental studies, which could lead to the discovery of new treatment options.
New medical claims have brought once illicit drugs back into fashion, argues Cambridge University fellow Victoria Harris, showing how capricious our attitudes toward drugs really are.
A new meta-analysis of research performed in the 60s and 70s shows LSD treated alcoholism significantly better than placebos. Scientists are taking another look at how psychedelics treat disease.
Hallucinogens are increasingly being studied for legitimate therapeutic uses, such as dealing with post-traumatic stress disorder, addiction, chronic pain, depression even terminal illness.
A single dose of the hallucinogen psilocybin, the active ingredient in 'magic mushrooms,' brings about a measurable and lasting personality change—'openness'—lasting at least a year.
A DIALOGUE BETWEEN JASON SILVA AND TECHNO-ECOLOGIC SCHOLAR RICHARD DOYLE Richard Doyle also goes by mobius, an indicator of just how important interconnections are to him – and how transformative, […]
"Scientists suggest that some psychedelics are remarkably good at treating disorders like depression and may now have a clue as to why." Studies on psychedelics may create new treatments.